Black Diamond Therapeutics (BDTX) Treasury Shares (2018 - 2019)

Black Diamond Therapeutics (BDTX) has reported Treasury Shares for 2 consecutive years, with $64.8 million the latest figure, recorded in Q4 2019.

• For the quarter ending Q4 2019, Treasury Shares rose 92.58% year-over-year to $64.8 million; the trailing twelve-month figure through Dec 2019 stood at $64.8 million (up 92.58% YoY), and the FY2019 full-year result was $64.8 million, up 92.58% from the prior year.
• Treasury Shares advanced to $64.8 million in Q4 2019 per BDTX's latest filing, from $45.4 million in the prior quarter.
• Across five years, Treasury Shares topped out at $64.8 million in Q4 2019 and bottomed at $33.7 million in Q4 2018.